参考文献/References:
[1]HASEGAWA M,TAIRA M,TOMINAGA Y,et al.Lack of bridge to recovery in pediatric dilated cardiomyopathy with left ventricular noncompaction[J].Annals of Thoracic Surgery Short Reports,2025,3(1):241-246.
[2]KALEKAR T,GUPTA A,KUMAR M.3-Tesla cardiac magnetic resonance imaging in primary dilated cardiomyopathy[J].Afr J Thorac Crit Care Med,2024,30(1):e844.
[3]ANTONOPOULOS A S,XINTARAKOU A,PROTONOTARIOS A,et al.Imagenetics for precision medicine in dilated cardiomyopathy[J].Circ Genom Precis Med,2024,17(2):e004301.
[4]王玲,鲁国卫,章宏,等.心脏磁共振参数列线图模型对扩张型心肌病老年患者不良心血管事件的预测价值[J].分子影像学杂志,2024,47(1):71-77.
[5]吴鹏,张海波,任平,等.心脏磁共振对扩张型心肌病患者左心室逆重构的评估价值[J].心脑血管病防治,2024,24(5):27-31.
[6]陈霞,陈小强,邹金国,等.重症监护病房老年心力衰竭患者心血管不良事件调查及影响因素分析[J].山西医药杂志,2025,54(2):107-110.
[7]COLAN S D,FELDMAN A M,GERSH B J,et al.2023 AHA/ACC guideline for the diagnosis and treatment of cardiomyopathies:A report of the american college of cardiology/american heart association guideline on the diagnosis and treatment of cardiomyopathies[J].Journal of the American College of Cardiology,2023,82(24):e265-e352.
[8]杨杰孚,廖玉华,袁璟,等.中国扩张型心肌病诊断和治疗指南[J].临床心血管病杂志,2018,34(5):421-434.
[9]EDA Y,NABETA T,IIKURA S,et al.Non-dilated left ventricular cardiomyopathy vs.dilated cardiomyopathy:Clinical background and outcomes[J].ESC Heart Fail,2024,11(3):1463-1471.
[10]刘涛,高晓坤,范茜寒,等.基于心脏磁共振探究扩张型心肌病患者经标准化抗心力衰竭药物治疗后左心室逆重构的预测因素[J].中国心血管杂志,2025,30(1):35-44.
[11]方淇民,张鑫,熊亮霞,等.多模态影像评估左室逆重构的研究进展[J].放射学实践,2024,39(4):558-562.
[12]刘晓洁,李慕嶂,陈佳莹,等.室间隔肌壁间纤维化与左束支传导阻滞的相关性及对新发左束支传导阻滞的预测价值[J].中国循证心血管医学杂志,2024,16(11):1335-1340.
[13]王素云.抗纤益心方逆转扩张型心肌病心室重构的巢式病例对照研究[D].郑州:河南中医药大学,2023.
[14]徐慧,李志刚,赵燕,等.影响扩张型心肌病患者心脏结构和功能发生逆转的相关因素分析[J].中华危重症医学杂志:电子版,2021,14(1):20-24.
[15]邵梦娇,石佳,王欢.系统免疫炎症指数对扩张型心肌病合并射血分数降低的心力衰竭患者左心室逆重构的预测价值[J].中国循环杂志,2024,39(7):695-702.
[16]朱慧敏,刘星婧,谷慧平.心率变异性联合TyG指数对糖尿病肾病患者MACE的预测价值[J].中南医学科学杂志,2024,52(6):911-914.
[17]董艳平,潘华峰,江志伟,等.基于心率变异度可视化分析加速康复外科策略对结直肠癌术后康复的影响[J].中国临床研究,2023,36(2):166-171.
[18]何小芳,邱兰.扩张型心肌病心率、血压控制幅度和心率变异 性联合评估患者预后的价值[J].海南医学,2018,29(14):1947-1950.
[19]吴鹏,张海波,任平,等.射血分数降低的扩张型心肌病患者左心室逆重构的预测因素及预后研究[J].中国循环杂志,2023,38(4):421-426.
[20]肖丽苗,陈文娟,彭颖慧,等.STI评估左心室逆重构扩张型心肌病患儿左心室收缩功能[J].中国医学影像技术,2018,34(9):1351-1355.
[21]宗敏,关晓楠,张建军.原发性扩张型心肌病左心室逆重构的预测因素[J].临床心血管病杂志,2021,37(9):846-849.
[22]UDELL J A,PETRIE M C,JONES W S,et al.Left ventricular function,congestion,and effect of empagliflozin on heart failure risk after myocardial infarction[J].J Am Coll Cardiol,2024,83(23):2233-2246.
[23]YOUNG J,LYNGBAKKEN N M,HVEEM K,et al.Systolic blood pressure,diastolic blood pressure and pulse pressure and the risk of subclinical myocardial injury:The HUNT study[J].Journal of the American Heart Association,2024:e031107.
[24]陈红莉,黄辉,王忠.左心室球形指数对扩张型心肌病预后预测价值的研究[J].安徽医科大学学报,2022,57(4):655-659.
[25]ADACHI Y,KIYOSUE A,ANDO J,et al.Factors associated with left ventricular reverse remodelling after percutaneous coronary intervention in patients with left ventricular systolic dysfunction[J].Sci Rep,2021,11(1):239.